---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-056688"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T04:34:17.231188+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Reaffirms FY2024 EPS >$34.29; CMS Star update adds ~$190M benefit

## Summary
- Net income guidance >$34.29/sh, includes ~$2.81/sh unfavorable items; adjusted >$37.10/sh.
- Four Medicare Advantage contracts received higher 2024 Star Ratings from CMS.
- ~49% of MA members now in plans rated 4-Star+ based on Jan 2024 enrollment.
- Estimated $190M financial benefit from reconsideration for payment year 2025.

## SEC filing metadata
- accession: 0001193125-24-056688
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312524056688/0001193125-24-056688-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312524056688/d806565d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-056688
- JSON: https://secwatch.observer/filing/0001193125-24-056688.json
- Plain text: https://secwatch.observer/filing/0001193125-24-056688.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.